Silverarc Capital Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6M | Sell |
410,000
-1,312
| -0.3% | -$37.3K | 2.15% | 17 |
|
|
2025
Q1 | $12.1M | Sell |
411,312
-132,339
| -24% | -$3.91M | 2.48% | 11 |
|
|
2024
Q4 | $15.8M | Buy |
543,651
+68,096
| +14% | +$1.98M | 3.46% | 10 |
|
|
2024
Q3 | $21.8M | Sell |
475,555
-42,179
| -8% | -$1.94M | 4.91% | 4 |
|
|
2024
Q2 | $21.1M | Buy |
517,734
+28,431
| +6% | +$1.16M | 4.99% | 3 |
|
|
2024
Q1 | $12.5M | Buy |
+489,303
| New | +$12.5M | 3.47% | 7 |
|
|
2023
Q1 | – | Sell |
-128,000
| Closed | -$2.84M | – | 91 |
|
|
2022
Q4 | $2.84M | Buy |
+128,000
| New | +$2.84M | 0.81% | 37 |
|